Big Pharma
Why the Antitrust Agencies Should Consider Prior Bad Acts in Merger Review
As the federal antitrust agencies consider revising the merger guidelines, they should add consideration of the merging parties’ previous bad acts, write Michael A....
How to Save American Middle-Sized Businesses from the Coronavirus Supply-Chain Crisis
Congress passed an $8.3 billion spending bill to address the coronavirus epidemic, but the bill will not protect small companies. Republican Senator Marco Rubio put forward...
The Amazon of Health Care: How CVS Is Evolving From a Drug Store Chain into a Tech Platform
CVS is built on a dominant chain of drug stores, but it is now trying to turn itself into a "uniquely powerful platform" for...
The Rise of the Opioids: How Purdue Invented New Markets for OxyContin
Purdue's strategy was to market its opioids directly to patients via brochures, videos, advertisements, and the internet. It also provided information to doctors and...
Purdue Circumvented the Regulator to Promote OxyContin, Hiding Its Real Risk of Addiction
In 2001, the Food and Drug Administration required Purdue to change OxyContin’s patient package inserts to make addiction risks more evident. The company altered...
